Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer? (2021)

First Author: Baker SC
Attributed to:  Growing a community for health research translation at York funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2020.11.008

PubMed Identifier: 33203550

Publication URI: http://europepmc.org/abstract/MED/33203550

Type: Journal Article/Review

Volume: 79

Parent Publication: European urology

Issue: 3

ISSN: 0302-2838